EIREX and DiagnaMed Collaborate on Revolutionary Hydrogen Technology Advancement
Key Ideas
- DiagnaMed Holdings Corp. and EIREX have entered into a collaboration agreement for the development of EIREX's modular carbon-free technology aimed at extracting hydrogen from water at significantly lower costs than traditional electrolysis methods.
- EIREX's hydrogen technology targets a cost of $0.25 per kilogram for commercial units, which is a fraction of the $2 per kilogram industry target set for 2030, potentially revolutionizing the hydrogen production market.
- The collaboration aims to advance the commercial pilot prototype of EIREX's technology, focusing on applications in industrial plants, medical centers, and for various medical treatments, harnessing the antioxidant and anti-inflammatory properties of molecular hydrogen.
- The partnership between DiagnaMed and EIREX also seeks to establish partnerships with life sciences companies and medical centers to provide a reliable source of hydrogen for operational needs and medical applications, potentially benefiting patients with various chronic diseases and disorders.
DiagnaMed Holdings Corp. has announced a collaboration with EIREX, a hydrogen technology company, to advance the development and commercialization of EIREX's innovative hydrogen extraction technology. EIREX's modular carbon-free technology aims to produce hydrogen from water at a significantly lower cost than current electrolysis methods, targeting a cost of $0.25 per kilogram for commercial units, a fraction of the industry target of $2 per kilogram by 2030. The collaboration intends to focus on advancing the commercial pilot prototype of EIREX's technology, with a particular emphasis on applications in industrial settings and medical centers, tapping into the antioxidant and anti-inflammatory properties of molecular hydrogen. The partnership also aims to establish relationships with life sciences companies and medical facilities to provide a reliable hydrogen source for operational and medical purposes, potentially aiding patients with various chronic conditions. Both DiagnaMed and EIREX are optimistic about the potential impact of this collaboration in revolutionizing the hydrogen production market and creating new opportunities for sustainable and cost-effective energy solutions.